Design, synthesis and pharmacological evaluation of cyclic mimetics of the insulin-like peptide 3 (INSL3) B-chain

Journal of Peptide Science

Volumn 13, Issue 2, 2007, Pages 113-120

  Shabanpoor, Fazel ^a   Bathgate, Ross A D ^a   Hossain, Mohammed Akhter ^a   Giannakis, Eleni ^a   Wade, John D ^a   Hughes, Richard A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Circular dichroism; Cyclic peptide; Disulfide; Helix mimetic; Insulin like peptide 3 (INSL3); LGR8; Peptide synthesis; Radioligand binding

Indexed keywords

DIPEPTIDE DERIVATIVE; DISULFIDE; G PROTEIN COUPLED RECEPTOR; INSULIN LIKE PEPTIDE 3; PEPTIDE; PEPTIDE HORMONE; PHOSPHORUS 33; RELAXIN; UNCLASSIFIED DRUG;

ALPHA HELIX; ARTICLE; BETA CHAIN; CIRCULAR DICHROISM; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; HUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROCESS DESIGN; PROTEIN CONFORMATION; SOLID PHASE SYNTHESIS; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING;

AMINO ACID SEQUENCE; BINDING, COMPETITIVE; CELL LINE; CIRCULAR DICHROISM; HUMANS; INSULIN; KIDNEY; KINETICS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES, CYCLIC; PROTEIN CONFORMATION; PROTEINS;

EID: 33847136099     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.807     Document Type: Article

References (28)

1. Kumagai J, Hsu SY, Matsumi H, Rob JS, Fu P, Wade JD, Bathgate RA, Hsueh AJ. INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent. J. Biol. Chem. 2002; 277: 31283-31286.
2. Hsu SY, Nakabayashi K, Nishi S, Kumagai J. Kudo M, Sherwood OD, Hsueh AJ. Activation of orphan receptors by the hormone relaxin. Science 2002; 295: 671-674.
3. Sudo S, Kumagai J, Nishi S, Layfield S, Ferraro T, Bathgate RA, Hsueh AJ. H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2. J. Biol. Chem. 2003; 278: 7855-7862.
4. Halls ML, Bond CP, Sudo S, Kumagai J, Ferraro T, Layfield S, Bathgate RA, Summers RJ. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8). J. Pharmacol. Exp. Ther. 2005; 313: 677-687.
5. Scott DJ, Fu P, Shen PJ, Gundlach A, Layfield S, Riesewijk A, Tomiyama H, Hutson JM, Tregear GW, Bathgate RA. Characterization of the rat INSL3 receptor. Ann. N.Y. Acad. Sci. 2005; 1041: 13-16.
6. Bathgate RA, Ivell R, Sanborn BM, Sherwood OD, Summers RJ. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol. Rev. 2006; 58: 7-31.
7. Tashima LS, Hicber AD, Greenwood FC, Bryant-Greenwood GD. The human Leydig insulin-like (hLEY l-L) gene is expressed in the corpus luteum and trophoblast. J. Clin. Endocrinol. Metab. 1995; 80: 707-710.
8. Roche PJ, Butkus A, Wintour EM, Tregear G. Structure and expression of Leydig insulin-like peptide mRNA in the sheep. Mol. Cell. Endocrinol. 1996; 121: 171-177.
9. Anand-lvell RJ, Relan V, Balvers M, Coiffec-Dorval I, Fritsch M, Bathgate RA, Ivell R. Expression of the insulin-like peptide 3 (INSL3) hormone-receptor (LGR8) system in the testis. Biol. Reprod. 2006; 74: 945-953.
10. Nef S, Parada LF. Cryptorchidism in mice mutant for Ins13. Nat. Genet. 1999; 22: 295-299.
11. Zimmermann S, Steding G, Emmen JM, Brinkmann AO, Nayernia K, Holstein AF, Engel W, Adham IM. Targeted disruption of the Ins13 gene causes bilateral cryptorchidism. Mol. Endocrinol. 1999; 13: 681-691.
12. Gorlov IP, Kamat A, Bogatcheva NV, Jones E, Lamb DJ, Truong A, Bishop CE, McElreavey K, Agoulnik AI. Mutations of the GREAT gene cause cryptorchidism. Hum. Mol. Genet. 2002; 11: 2309-2318.
13. Adham IM, Steding G, Thamm T, Bullesbach EE, Schwabe C, Paprotta I, Engel W. The overexpression of the ins13 in female mice causes descent of the ovaries. Mol. Endocrinol. 2002; 16: 244-252.
14. Kawamura K, Kumagai J, Sudo S, Chun SY, Pisarska M, Morita H, Toppari J, Fu P, Wade JD, Bathgate RA, Hsueh AJ. Paracrine regulation of mammalian oocyte maturation and male germ cell survival. Proc. Natl. Acad. Sci. U.S.A. 2004; 101: 7323-7328.
15. Bathgate RAD, Hsueh AJW, Sherwood OD. Physiology and molecular biology of the relaxin peptide family, in Knobil and Neill's Physiology of Reproduction, Neill JD (ed). Academic Press: San Diego, 2005; pp. 679-768.
16. Rosengren KJ, Zhang S, Lin F, Daly NL, Scott DJ, Hughes RA, Bathgate RA, Craik DJ, Wade JD. Solution structure and characterization of the LGR8 receptor binding surface of insulin-like peptide 3. J. Biol. Chem. 2006; 281: 28287-28295.
17. Bullesbach EE, Schwabe C. Synthetic cross-links arrest the C-terminal region of the relaxin-like factor in an active conformation. Biochemistry 2004; 43: 8021-8028.
18. Bunesbach EE, Schwabe C. Tryptophan B27 in the relaxin-like factor (RLF) is crucial for RLF receptor-binding. Biochemistry 1999; 38: 3073-3078.
19. Eigenbrot C, Randal M, Quan C, Burnier J, O'Connell L, Rinderknecht E, Kossiakoff AA. X-ray structure of human relaxin at 1.5 A. Comparison to insulin and implications for receptor binding determinants. J. Mol. Biol. 1991; 221: 15-21.
20. Tan YY, Wade JD, Tregear GW, Summers RJ. Quantitative autoradiographic studies of relaxin binding in rat atria, uterus and cerebral cortex: characterization and effects of oestrogen treatment. Br. J. Pharmacol. 1999; 127: 91-98.
21. Bernatowicz MS, Daniels SB, Koster H. A comparison of acid labile linkage agents for the synthesis of peptide C-terminal amides. Tetrahedron Lett. 1989; 30: 4645-4648.
22. Knorr R, Trzeciak A, Bannwarth W, Gillesen D. New coupling reagents in peptide chemistry. Tetrahedron Lett. 1989; 30: 1927-1930.
23. Sampson WR, Patsiouras H, Ede NJ. The synthesis of difficult peptides using 2-hydroxy-4-methoxybenzyl or pseudoproline amino acid building blocks: a comparative study. J. Pept. Sci. 1999; 5: 403-409.
24. Hancock WS, Battersby JE. New Micro-test for detection of incomplete coupling reactions in solid-phase peptide synthesis using 2,4,6-Trinitrobenzene-sulphonic acid. Anal. Biochem. 1976; 71: 260-264.
25. Dawson NF, Tan YY, Macris M, Otvos L Jr, Summers RJ, Tregear GW, Wade JD. Solid-phase synthesis of ovine Leydig cell insulin-like peptide - a putative ovine relaxin? J. Pept. Res. 1999; 53: 542-547.
26. Muda M, He C, Martini PG, Ferraro T, Layfield S, Taylor D, Chevrier C, Schweickhardt R, Kelton C, Ryan PL, Bathgate RA. Splice variants of the relaxin and INSL3 receptors reveal unanticipated molecular complexity. Mol. Hum. Reprod. 2005; 11: 591-600.
27. Del Borgo MP, Hughes RA, Bathgate RA, Lin F, Kawamura K, Wade JD. Analogs of insulin-like peptide 3 (1NSL3) B-chain are LGR8 antagonists in vitro and in vivo. d. Biol. Chem. 2006; 281: 13068-13074.
28. Haack T, Mutter M. Serine derived oxazolidines as secondary structure disrupting, solubilizing building blocks in peptide synthesis. Tetrahedron Lett. 1992; 33:1589-1592.